TR199900527T2 - Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi. - Google Patents

Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi.

Info

Publication number
TR199900527T2
TR199900527T2 TR1999/00527T TR9900527T TR199900527T2 TR 199900527 T2 TR199900527 T2 TR 199900527T2 TR 1999/00527 T TR1999/00527 T TR 1999/00527T TR 9900527 T TR9900527 T TR 9900527T TR 199900527 T2 TR199900527 T2 TR 199900527T2
Authority
TR
Turkey
Prior art keywords
treatment
neurological disorders
pain
neuralgia
benzopyranols
Prior art date
Application number
TR1999/00527T
Other languages
English (en)
Inventor
Parsons Andrew
Thompson Mervyn
Upton Neil
Morris Evans John
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR199900527T2 publication Critical patent/TR199900527T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Huntingdon koresi, sizofreni; AIDS, düzensiz uyku (sirkadyan ritim bozukluklari, uykusuzluk ve narkolepsi dahil), tikler (örnegin Giles de la Tourette sendromu), travmatik beyin hasari, tinnitus, nöralji, özellikle trigeminal nöralji, nörofatik aci, dis agrisi, kanser agrisi; diyabetik, çoklu sikleroz (MS) ve motor sinir hastaligi, ataksiyaz, kas sertligi (spastiklik) ve temporomandibular eklem islemezligi gibi nörodisteziyaz ile sonuçlanan uygunsuz nöron faaliyeti ile ilgili nörolojik bozukluklar gibi dejeneratif bozukluklarin tedavisi ve/veya profilaksisi için, faydali benzopiran türevleri ve benzerleri kapsamda yer almaktadir.
TR1999/00527T 1996-09-18 1997-09-15 Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi. TR199900527T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment

Publications (1)

Publication Number Publication Date
TR199900527T2 true TR199900527T2 (tr) 1999-06-21

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00527T TR199900527T2 (tr) 1996-09-18 1997-09-15 Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi.

Country Status (30)

Country Link
EP (1) EP0939630B1 (tr)
JP (1) JP2001500520A (tr)
KR (1) KR20000036184A (tr)
CN (1) CN1230885A (tr)
AP (1) AP9901473A0 (tr)
AR (1) AR008838A1 (tr)
AT (1) ATE270102T1 (tr)
AU (1) AU730465B2 (tr)
BG (1) BG103252A (tr)
BR (1) BR9712030A (tr)
CA (1) CA2266681A1 (tr)
DE (1) DE69729735T2 (tr)
DZ (1) DZ2311A1 (tr)
EA (1) EA199900306A1 (tr)
ES (1) ES2223075T3 (tr)
GB (1) GB9619492D0 (tr)
HU (1) HUP9904638A3 (tr)
ID (2) ID23175A (tr)
IL (1) IL128786A0 (tr)
MA (1) MA24321A1 (tr)
NO (1) NO991292L (tr)
NZ (1) NZ334271A (tr)
OA (1) OA10998A (tr)
PE (1) PE109898A1 (tr)
PL (1) PL332313A1 (tr)
SK (1) SK35199A3 (tr)
TR (1) TR199900527T2 (tr)
UY (1) UY24717A1 (tr)
WO (1) WO1998011890A1 (tr)
ZA (1) ZA978359B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20110319482A1 (en) * 2008-06-05 2011-12-29 Peter Blower Novel treatments
EP2307004A1 (en) * 2008-06-05 2011-04-13 Minster Research Limited Novel treatments
US8952034B2 (en) 2009-07-27 2015-02-10 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
CA2782631A1 (en) * 2009-12-03 2011-06-09 Proximagen Ltd Treatment of infectious diseases
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
BR112012033402A2 (pt) 2010-07-02 2017-01-24 Gilead Sciences Inc moduladores de canais de íons conforme os compostos heterocíclicos fundidos
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (tr) 2011-07-01 2018-04-28
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
HUT76136A (en) * 1994-06-10 1997-06-30 Smithkline Beecham Plc Benzopyran compounds and their use as therapeutic agents
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
UY24717A1 (es) 2001-08-27
DE69729735D1 (de) 2004-08-05
BR9712030A (pt) 1999-08-24
GB9619492D0 (en) 1996-10-30
CN1230885A (zh) 1999-10-06
HUP9904638A2 (hu) 2001-05-28
ATE270102T1 (de) 2004-07-15
OA10998A (en) 2003-03-04
PE109898A1 (es) 1999-03-21
AR008838A1 (es) 2000-02-23
IL128786A0 (en) 2000-01-31
NO991292D0 (no) 1999-03-17
AU4704797A (en) 1998-04-14
ES2223075T3 (es) 2005-02-16
PL332313A1 (en) 1999-08-30
ID23175A (id) 2000-03-23
DE69729735T2 (de) 2005-07-14
EA199900306A1 (ru) 1999-08-26
CA2266681A1 (en) 1998-03-26
HUP9904638A3 (en) 2001-08-28
EP0939630A1 (en) 1999-09-08
AP9901473A0 (en) 1999-03-31
JP2001500520A (ja) 2001-01-16
ZA978359B (en) 1999-03-17
DZ2311A1 (fr) 2002-12-28
ID19542A (id) 1998-07-23
AU730465B2 (en) 2001-03-08
KR20000036184A (ko) 2000-06-26
WO1998011890A1 (en) 1998-03-26
NO991292L (no) 1999-03-17
EP0939630B1 (en) 2004-06-30
BG103252A (en) 1999-09-30
SK35199A3 (en) 2000-07-11
NZ334271A (en) 2001-03-30
MA24321A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
LTIP919A (en) Drugs and process for preparing thereof
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
AU2267192A (en) Treatment of migraine by nerve stimulation
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
AU2259292A (en) Treatment of neuropsychiatric disorders by nerve stimulation
AU2339792A (en) Treatment of respiratory disorders by nerve stimulation
ATE192045T1 (de) Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose
TR199900527T2 (tr) Nörolojik bozukluklarin tedavisi için benzopiranollerin kullanimi.
AU2399892A (en) Treatment of anxiety disorders by nerve stimulation
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
AU2173400A (en) Method for administering agents to the central nervous system
PT655243E (pt) Derivados da melatonina para utilizacao no tratamento de disturbios do sono
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
EP1416282A3 (en) Method for screening compounds for treating bone disorders
EP0745597A3 (en) Novel melatonergic indanyl piperazines or homopiperazines
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
ECSP972256A (es) Nuevo tratamiento y/o profilaxis de enfermedades degenerativas
RU94034011A (ru) Способ лечения психического расстройства
RU94039254A (ru) Способ управления физиологическим состоянием организма в геронтологическом периоде онтогенеза